# Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers

> **NCT03754465** · PHASE2 · COMPLETED · sponsor: **Anterogen Co., Ltd.** · enrollment: 66 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **BIOLOGICAL:** ALLO-ASC-DFU
- **PROCEDURE:** Hydrogel SHEET(Vehicle control)

## Key facts

- **NCT ID:** NCT03754465
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-02
- **Primary completion:** 2023-10-23
- **Final completion:** 2023-10-23
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03754465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03754465, "Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03754465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*